169 related articles for article (PubMed ID: 8810734)
1. Effects of glucose load and/or arginine on insulin and growth hormone secretion in hyperprolactinemia and obesity.
Maccario M; Grottoli S; Razzore P; Procopio M; Oleandri SE; Ciccarelli E; Camanni F; Ghigo E
Eur J Endocrinol; 1996 Aug; 135(2):205-10. PubMed ID: 8810734
[TBL] [Abstract][Full Text] [Related]
2. The inhibitory effect of glucose on growth hormone secretion is lost in obesity but not in hypertension.
Limone P; Oleandri SE; Ajmone Catt P; Grottoli S; Frangioni C; Avogadri E; Perrin M; Valetto MR; Maccario M
J Endocrinol Invest; 1997 Nov; 20(10):616-20. PubMed ID: 9438920
[TBL] [Abstract][Full Text] [Related]
3. In obesity, glucose load loses its early inhibitory, but maintains its late stimulatory, effect on somatotrope secretion.
Grottoli S; Procopio M; Maccario M; Zini M; Oleandri SE; Tassone F; Valcavi R; Ghigo E
J Clin Endocrinol Metab; 1997 Jul; 82(7):2261-5. PubMed ID: 9215304
[TBL] [Abstract][Full Text] [Related]
4. Effects of acipimox, an antilipolytic drug, on the growth hormone (GH) response to GH-releasing hormone alone or combined with arginine in obesity.
Maccario M; Procopio M; Grottoli S; Oleandri SE; Boffano GM; Taliano M; Camanni F; Ghigo E
Metabolism; 1996 Mar; 45(3):342-6. PubMed ID: 8606641
[TBL] [Abstract][Full Text] [Related]
5. Somatotrope responsiveness to Hexarelin, a synthetic hexapeptide, is refractory to the inhibitory effect of glucose in obesity.
Grottoli S; Maccario M; Procopio M; Oleandri SE; Arvat E; Gianotti L; Deghenghi R; Camanni F; Ghigo E
Eur J Endocrinol; 1996 Dec; 135(6):678-82. PubMed ID: 9025712
[TBL] [Abstract][Full Text] [Related]
6. Effects of 36 hour fasting on GH/IGF-I axis and metabolic parameters in patients with simple obesity. Comparison with normal subjects and hypopituitary patients with severe GH deficiency.
Maccario M; Aimaretti G; Grottoli S; Gauna C; Tassone F; Corneli G; Rossetto R; Wu Z; Strasburger CJ; Ghigo E
Int J Obes Relat Metab Disord; 2001 Aug; 25(8):1233-9. PubMed ID: 11477509
[TBL] [Abstract][Full Text] [Related]
7. Short-term fasting in obesity fails to restore the blunted GH responsiveness to GH-releasing hormone alone or combined with arginine.
Procopio M; Maccario M; Grottoli S; Oleandri SE; Boffano GM; Camanni F; Ghigo E
Clin Endocrinol (Oxf); 1995 Dec; 43(6):665-9. PubMed ID: 8736266
[TBL] [Abstract][Full Text] [Related]
8. Effects of recombinant human insulin-like growth factor I administration on the growth hormone (gh) response to GH-releasing hormone in obesity.
Maccario M; Tassone F; Gianotti L; Lanfranco F; Grottoli S; Arvat E; Muller EE; Ghigo E
J Clin Endocrinol Metab; 2001 Jan; 86(1):167-71. PubMed ID: 11231996
[TBL] [Abstract][Full Text] [Related]
9. Interactions of galanin and arginine on growth hormone, prolactin, and insulin secretion in man.
Ghigo E; Maccario M; Arvat E; Valetto MR; Valente F; Nicolosi M; Mazza E; Martina V; Cocchi D; Camanni F
Metabolism; 1992 Jan; 41(1):85-9. PubMed ID: 1371576
[TBL] [Abstract][Full Text] [Related]
10. Both fasting-induced leptin reduction and GH increase are blunted in Cushing's syndrome and in simple obesity.
Grottoli S; Gauna C; Tassone F; Aimaretti G; Corneli G; Wu Z; Strasburger CJ; Dieguez C; Casanueva FF; Ghigo E; Maccario M
Clin Endocrinol (Oxf); 2003 Feb; 58(2):220-8. PubMed ID: 12580939
[TBL] [Abstract][Full Text] [Related]
11. In obesity the somatotrope response to either growth hormone-releasing hormone or arginine is inhibited by somatostatin or pirenzepine but not by glucose.
Maccario M; Procopio M; Grottoli S; Oleandri SE; Razzore P; Camanni F; Ghigo E
J Clin Endocrinol Metab; 1995 Dec; 80(12):3774-8. PubMed ID: 8530634
[TBL] [Abstract][Full Text] [Related]
12. Effect of central cholinergic neurotransmission enhancement by pyridostigmine on the growth hormone secretion elicited by clonidine, arginine, or hypoglycemia in normal and obese subjects.
Cordido F; Dieguez C; Casanueva FF
J Clin Endocrinol Metab; 1990 May; 70(5):1361-70. PubMed ID: 2159483
[TBL] [Abstract][Full Text] [Related]
13. Effects of short-term administration of low-dose rhGH on IGF-I levels in obesity and Cushing's syndrome: indirect evaluation of sensitivity to GH.
Maccario M; Tassone F; Gauna C; Oleandri SE; Aimaretti G; Procopio M; Grottoli S; Pflaum CD; Strasburger CJ; Ghigo E
Eur J Endocrinol; 2001 Mar; 144(3):251-6. PubMed ID: 11248744
[TBL] [Abstract][Full Text] [Related]
14. GH response to GHRH combined with pyridostigmine or arginine in different conditions of low somatotrope secretion in adulthood: obesity and Cushing's syndrome in comparison with hypopituitarism.
Procopio M; Maccario M; Savio P; Valetto MR; Aimaretti G; Grottoli S; Oleandri SE; Baffoni C; Tassone F; Arvat E; Camanni F; Ghigo E
Minerva Endocrinol; 1999; 24(3-4):107-11. PubMed ID: 10953725
[TBL] [Abstract][Full Text] [Related]
15. GH response to GHRH combined with pyridostigmine or arginine in different conditions of low somatotrope secretion in adulthood: obesity and Cushing's syndrome in comparison with hypopituitarism.
Procopio M; Maccario M; Savio P; Valetto MR; Aimaretti G; Grottoli S; Oleandri SE; Baffoni C; Tassone F; Arvat E; Camanni F; Ghigo E
Panminerva Med; 1998 Mar; 40(1):13-7. PubMed ID: 9573747
[TBL] [Abstract][Full Text] [Related]
16. Effect of arginine and pyridostigmine on the GHRH-induced GH rise in obesity and Cushing's syndrome.
Procopio M; Invitti C; Maccario M; Grottoli S; Cavagnini F; Camanni F; Ghigo E
Int J Obes Relat Metab Disord; 1995 Feb; 19(2):108-12. PubMed ID: 7735336
[TBL] [Abstract][Full Text] [Related]
17. The study of spontaneous GH secretion after 36-h fasting distinguishes between GH-deficient and normal adults.
Aimaretti G; Colao A; Corneli G; Pivonello R; MacCario M; Morrison K; Pflaum CD; Strasburger CJ; Lombardi G; Ghigo E
Clin Endocrinol (Oxf); 1999 Dec; 51(6):771-7. PubMed ID: 10619983
[TBL] [Abstract][Full Text] [Related]
18. Cholinergic enhancement by pyridostigmine increases the insulin response to glucose load in obese patients but not in normal subjects.
Del Rio G; Procopio M; Bondi M; Marrama P; Menozzi R; Oleandri SE; Grottoli S; Maccario M; Velardo A; Ghigo E
Int J Obes Relat Metab Disord; 1997 Dec; 21(12):1111-4. PubMed ID: 9426377
[TBL] [Abstract][Full Text] [Related]
19. The negative association between total ghrelin levels, body mass and insulin secretion is lost in hypercortisolemic patients with Cushing's disease.
Giordano R; Picu A; Pagotto U; De Iasio R; Bonelli L; Prodam F; Broglio F; Marafetti L; Pasquali R; Maccario M; Ghigo E; Arvat E
Eur J Endocrinol; 2005 Oct; 153(4):535-43. PubMed ID: 16189175
[TBL] [Abstract][Full Text] [Related]
20. IGF-1 levels in different conditions of low somatotrope secretion in adulthood: obesity in comparison with GH deficiency.
Maccario M; Grottoli S; Aimaretti G; Gianotti L; Endrio Oleandri S; Procopio M; Savio P; Tassone F; Ramunni J; Camanni F; Ghigo E
Minerva Endocrinol; 1999 Jun; 24(2):57-61. PubMed ID: 10941424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
